purevax rabies
boehringer ingelheim vetmedica gmbh - vcp65-virus - immunologiska - katter - aktiv immunisering av katter 12 veckors ålder och äldre för att förhindra dödlighet på grund av rabiesinfektion. immunitetens början: 4 veckor efter primärvaccinationen. immunitetens varaktighet efter primärvaccination: 1 år. immunitetens varaktighet efter revaccination: 3 år.
rabies-imovax 2,5 iu pulver och vätska till injektionsvätska, suspension
sanofi pasteur europe - rabiesvirus, stam wistar pm/wi 38-1503-3m, inaktiverat - pulver och vätska till injektionsvätska, suspension - 2,5 iu - rabiesvirus, stam wistar pm/wi 38-1503-3m, inaktiverat 2,5 ie aktiv substans - inaktiverat helvirusvaccin
nobivac rabies vet. 2 ie injektionsvätska, suspension
intervet international b.v. - rabiesvirus, stam pasteur riv, inaktiverat - injektionsvätska, suspension - 2 ie - tiomersal hjälpämne; aluminiumfosfat 3 mg adjuvans; rabiesvirus, stam pasteur riv, inaktiverat 2 ie aktiv substans - rabiesvirus - får, get, hund, häst, iller, katt, nöt, räv
nobivac rabies vet. 2 ie injektionsvätska, suspension
europharmadk aps - rabiesvirus, stam pasteur riv, inaktiverat - injektionsvätska, suspension - 2 ie - tiomersal hjälpämne; glukos (vattenfri) hjälpämne; rabiesvirus, stam pasteur riv, inaktiverat 2 ie aktiv substans; aluminiumfosfat 3 mg adjuvans - rabiesvirus - får, get, hund, häst, iller, katt, nöt, räv
versiguard rabies vet. injektionsvätska, suspension
zoetis animal health aps - rabiesvirus, stam vnukovo-32, inaktiverat - injektionsvätska, suspension - tiomersal hjälpämne; aluminiumoxid, hydratiserad 2 mg adjuvans; rabiesvirus, stam vnukovo-32, inaktiverat 2 ie aktiv substans - rabiesvirus - får, get, hund, häst, iller, katt, nöt, svin
purevax rcp felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals för kattdjur, - katter - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcpch felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologicals för kattdjur, - katter - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
nobivac rabies vet. 2 ie injektionsvätska, suspension
orifarm ab - rabiesvirus, stam pasteur riv, inaktiverat - injektionsvätska, suspension - 2 ie - rabiesvirus, stam pasteur riv, inaktiverat 2 ie aktiv substans; tiomersal hjälpämne; aluminiumfosfat 3 mg adjuvans - får, get, hund, häst, iller, katt, nöt, räv
nobivac rabies vet. 2 ie injektionsvätska, suspension
orifarm ab - rabiesvirus, stam pasteur riv, inaktiverat - injektionsvätska, suspension - 2 ie - aluminiumfosfat 3 mg adjuvans; rabiesvirus, stam pasteur riv, inaktiverat 2 ie aktiv substans; tiomersal hjälpämne - får, get, hund, häst, iller, katt, nöt, räv
purevax rabies
merial s.a.s. - rabiesvirusantigener: rekombinant rabiesvirusantigener: rekombinant kanariefågelpoxvirus (vcp65) - injektionsvätska, suspension - katt